Rate My Professor Emily Douglas

Emily Douglas contributes significantly to clinical research efforts centered on mood disorders and youth mental health. She is designated as the contact person for the Targeting Functional Recovery in Mood Disorders study, available to provide further details via telephone at 03 372 6700 or email. Furthermore, she acts as a co-ordinator for the Weaving our own path project, alongside Andrea Bartram, reaching out to potential participants for this youth mental health research effort. Her involvement is recognized in acknowledgments across multiple peer-reviewed publications emerging from the Department of Psychological Medicine. These include Predicting Cognitive Change During Treatment for Inpatient Depression (2025), where she is credited as research assistant; Forecasting the course of bipolar disorder using rest-activity rhythms (2025), thanking Ms Emily Douglas; Impact of Activation Therapy on Cognition in Inpatient Depression (2023), noting her superb organisation and cognitive testing support; Cognitive predictors of response to interpersonal and social rhythm therapy for bipolar disorders (2024), acknowledging her as research assistant; Examining the long-term cognitive effects of exposure to the Canterbury earthquakes in a resilient cohort (2022), for administration of cognitive testing; Randomised controlled trial of Interpersonal and Social Rhythm Therapy and group-based Cognitive Remediation versus Interpersonal and Social Rhythm Therapy alone for mood disorders study protocol (2022), listing her among research assistants; understanding neurocognitive impairment after trauma exposure study protocol (2023), as research assistant; and Protocol for a randomised controlled trial of ketamine versus ketamine and behavioural activation therapy for adults with treatment-resistant depression in the community (2024), mentioning Emily Douglas among research staff. These works address critical areas such as cognitive changes in treatment, rest-activity rhythms in bipolar disorder, activation therapy impacts, earthquake trauma effects, and novel interventions for treatment-resistant depression.